References
- Deceased donor transplants in the U.S by state [Internet]. 2021. [cited 2021 Nov 17]. Available from: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/.
- Sussell J, Silverstein AR, Goutam P, et al. The economic burden of kidney graft failure in the United States. Am J Transplant. 2020;20(5):1323–1333.
- USRDS. 2021 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda (MD): United States Renal Data System; 2020.
- Kaballo MA, Canney M, O'Kelly P, et al. A comparative analysis of survival of patients on dialysis and after kidney transplantation. Clin Kidney J. 2018;11(3):389–393.
- McCaughan JA, Patterson CC, Maxwell AP, et al. Factors influencing survival after kidney transplant failure. Transplant Res. 2014;3(1):18.
- Loupy A, Haas M, Roufosse C, et al. The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant. 2020;20(9):2318–2331.
- Halloran PF, Pereira AB, Chang J, et al. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: the INTERCOM study. Am J Transplant. 2013;13(9):2352–2363.
- Reeve J, Böhmig GA, Eskandary F, et al. Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers. Am J Transplant. 2019;19(10):2719–2731.
- Halloran PF, Reeve J, Akalin E, et al. Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study. Am J Transplant. 2017;17(11):2851–2862.
- Rush D. Can protocol biopsy better inform our choices in renal transplantation? Transplant Proc. 2009;41(6 Suppl):S6–S8.
- Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project11A complete listing of the participants who all contributed equally to the work of the CERTPAP project includes peter N. Furness (Leicester, UK); NIC. Kidney Int. 2001;60(5):1998–2012.
- Reeve J, Sellarés J, Mengel M, et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant. 2013;13(3):645–655.
- Furness PN, Taub N, Assmann KJ. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol. 2003;27(6):805–810.
- Sellarés J, Reeve J, Loupy A, et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant. 2013;13(4):971–983.
- Famulski KS, de Freitas DG, Kreepala C, et al. Molecular phenotypes of acute kidney injury in kidney transplants. J Am Soc Nephrol. 2012;23(5):948–958.
- Madill-Thomsen KS, Reeve J, Bohmig G, et al. editors. Automated histology lesion interpretation in kidney transplant biopsies shows that pathologists often deviate from Banff guidelines. American Transplant Congress; 2019. American Society of Transplantation and the American Society of Transplant Surgeons.
- Becker JU, Chang A, Nickeleit V, et al. Banff borderline changes suspicious for acute T cell-mediated rejection: where do we stand? Am J Transplant. 2016;16(9):2654–2660.
- Roufosse C, Simmonds N, Clahsen-van Groningen M, et al. A 2018 reference guide to the Banff classification of renal allograft pathology. Transplantation. 2018;102(11):1795–1814.
- Madill-Thomsen KS, Wiggins RC, Eskandary F, et al. The effect of cortex/medulla proportions on molecular diagnoses in kidney transplant biopsies: rejection and injury can be assessed in medulla. Am J Transplant. 2017;17(8):2117–2128.
- Einecke G, Reeve J, Gupta G, et al. Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: importance of parenchymal injury but not disease activity. Am J Transplant. 2021;21(4):1391–1401.
- Halloran PF, Chang J, Famulski K, et al. Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients. J Am Soc Nephrol. 2015;26(7):1711–1720.
- Madill-Thomsen K, Perkowska-Ptasinska A, Bohmig GA, et al. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies. Am J Transplant. 2020;20(5):1341–1350.
- Payments and Claims by DRG Code - Medicare [Internet]. Baltimore (MD): Definitive healthcare. 2021. [cited 2021 Sept 07]. Available from: https://www.definitivehc.com/.
- Kaplan B, Meier-Kriesche H-U. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant. 2002;2(10):970–974.
- CMS Manual System-Pub 100-04 Medicare Claims Processing [Internet]. Baltimore (MD): CMS Database; 2021. [cited 2021 Nov 09]. Available from: https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2019Downloads/R4326CP.pdf.
- CMS Clinical Laboratory Fee Schedule (CLFS) Annual Public Meeting [Internet]. Baltimore (MD): CMS Database; 2021. [cited 2021 Nov 09]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Laboratory_Public_Meetings.
- Johnson B, Kennedy K, Kurowski D. Comparing commercial and Medicare professional service prices: health care cost Institute; 2020. [cited 2021 Nov 21]. Available from: https://healthcostinstitute.org/hcci-research/comparing-commercial-and-medicare-professional-service-prices.
- ICD-10-CM/PCS MS-DRG v37.0 definitions manual [Internet]. Baltimore (MD): CMS Database; [cited 2021 Nov 09]. Available from: https://www.cms.gov/icd10m/version37-fullcode-cms/fullcode_cms/P1151.html.
- Table 5 (FY 2021 Final rule and correction notice MS-DRGs, relative weighting factors and geometric and arithmetic mean length of stay) [Internet]. Baltimore (MD): CMS Database; 2021. [cited 2021 Nov 09]. Available from: https://www.cms.gov/medicare/acute-inpatient-pps/fy-2021-ipps-final-rule-home-page#Tables.
- Lopez E, Neuman T, Jacobson G, et al. How much more than medicare do private insurers pay? A review of the literature: Kaiser Family Foundation. 2020. [cited 2021 Nov 09]. Available from: https://www.kff.org/medicare/issue-brief/how-much-more-than-medicare-do-private-insurers-pay-a-review-of-the-literature/.
- Schnitzler MA, Skeans MA, Axelrod DA, et al. OPTN/SRTR 2016 annual data report: Economics. Am J Transplant. 2018;18:464–503.
- CPI inflation calculator [Internet]. US Bureau of Labor Statistics. 2021. [cited 2021 Nov 09]. Available from: https://www.bls.gov/data/inflation_calculator.htm.
- Kumar D, Demehin M, Christensen J., et al. The role of the molecular microscope to guide therapy for T-cell mediated rejection in kidney transplants. 2020 American Transplant Congress; 2020.
- Lawrence C. Analysis of RNA transcripts by the molecular microscope diagnostic system (MMDx) can direct management after indication kidney transplant biopsy; 2020. 06/24.
- Lawrence C, Thiru S, Manoj A, et al. editors. First UK experience of the molecular microscope (MMDX™) in the kidney transplant clinic. 2019 American Transplant Congress; 2019.
- Myślak M, Deborska-Materkowska D, Ciszek M, et al., editors. The Polish troubled kidney transplant biopsy study: external validation of the molecular microscope system. 2019 American Transplant Congress; 2019.
- Naesens M, Kuypers DRJ, De Vusser K, et al. The histology of kidney transplant failure: a long-term follow-up study. Transplantation. 2014;98(4):427–435.
- Loupy A, Vernerey D, Tinel C, et al. Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts. JASN. 2015;26(7):1721–1731.
- Vargas GG, Caillard S, Parissiadis A, et al., editors. Identification and long-term consequences of antibodies which bound C1q in 118 kidney transplant recipients with donor specific antibodies. World Transplant Congress 2014; 2014.
- Lachmann N, Duerr M, Schönemann C, et al. Treatment of antibody-mediated renal allograft rejection: improving step by step. J Immunol Res. 2017;2017:6872046.
- Prescribing Information of THYMOGLOBULIN® FDA. [2021 Jul 29]. Available from: https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert-Thymoglobulin.pdf
- Tucker EL, Smith AR, Daskin MS, et al. Life and expectations post-kidney transplant: a qualitative analysis of patient responses. BMC Nephrol. 2019;20(1):175.
- Pinter J, Hanson CS, Chapman JR, et al. Perspectives of older kidney transplant recipients on kidney transplantation. Clin J Am Soc Nephrol. 2017;12(3):443–453.